688271.SH
联影医疗
SSE · Healthcare · Medical - Specialties · CN
CNY 105.40
−0.57%Year over year
Reported trailing growth
- Revenue
- +36.5%
- EBITDA
- —
- EBIT
- +53.0%
- EPS
- +48.9%
- Free cash flow
- +89.7%
- Operating cash flow
- +757.3%
Forward estimates
Based on analyst estimates
- Revenue
- +27.7%
- EBITDA
- +37.8%
- EPS
- +21.8%
Three-year CAGR
- Revenue
- +14.3%
- EBITDA
- +4.6%
- EBIT
- +1.2%
- Net income
- +4.1%
- EPS
- +1.4%
- Free cash flow
- +122.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026